Short-term effects of neuroactive pharmaceutical drugs on a fish species: Biochemical and behavioural effects

Aquatic Toxicology

Volumn 144-145, Issue , 2013, Pages 218-229

  Brandao F P ^a   Rodrigues, S ^b   Castro, B B ^a   Goncalves F ^a   Antunes, S C ^a,b   Nunes, B ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Behaviour; Carbamazepine; Diazepam; Lepomis gibbosus; Oxidative stress; Phenytoin

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CATALASE; DIAZEPAM; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; PEROXIDE; PHENYTOIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

BEHAVIORAL RESPONSE; BIOCHEMISTRY; DRUG; EFFLUENT; ENVIRONMENTAL IMPACT; ENZYME ACTIVITY; FISH; PHYSIOLOGICAL RESPONSE; POLLUTANT SOURCE; POLLUTION EXPOSURE; SEWAGE TREATMENT; TOXICITY;

ADAPTIVE BEHAVIOR; ANIMAL BEHAVIOR; ANIMAL TISSUE; AQUATIC ENVIRONMENT; ARTICLE; BEHAVIOR DISORDER; BIOCHEMISTRY; CONTROLLED STUDY; DIGESTIVE SYSTEM; DRUG TISSUE LEVEL; ECOTOXICITY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYME INHIBITION; FISH; GILL; LEPOMIS GIBBOSUS; LIPID PEROXIDATION; LIVER; METABOLIC PARAMETERS; MOTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SPECIES REFUGE; SWIMMING; TISSUE SECTION;

BEHAVIOUR; CARBAMAZEPINE; DIAZEPAM; LEPOMIS GIBBOSUS; OXIDATIVE STRESS; PHENYTOIN;

ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; ENZYME ACTIVATION; GASTROINTESTINAL TRACT; GILLS; GLUTATHIONE TRANSFERASE; LIVER; OXIDATIVE STRESS; PERCIFORMES; WATER POLLUTANTS, CHEMICAL;

EID: 84887001552     PISSN: 0166445X     EISSN: 18791514     Source Type: Journal    
DOI: 10.1016/j.aquatox.2013.10.005     Document Type: Article

References (89)

1. Abelaira H.M., Réus G.Z., Ribeiro K.F., Steckert A.V., Mina F., Rosa D.V.F., Santana C.V., Romano-Silva M.A., Dal-Pizzol F., Quevedo J. Effects of lamotrigine on behavior, oxidative parameters and signaling cascades in rats exposed to the chronic mild stress model. Neuroscience Research 2013, 75(4):324-330.
2. Abdelmajeed N.A. Diazepam-induced oxidative stress in rat different organs. Research Journal of Medicine and Medical Sciences 2009, 4:295-302.
3. Abramov J.P., Wells P.G. Embryonic catalase protects against endogenous and phenytoin-enhanced DNA oxidation and embryopathies in acatalasemic and human catalase-expressing mice. FASEB Journal 2011, 25:2188-2200.
4. Aebi H. Catalase in vitro. Methods in Enzymology 1984, 105:121-126.
5. Allam F., Dao A.T., Chugh G., Bohat R., Jafri F., Patki G., Mowrey C., Asghar M., Alkadhi K.A., Salim S. Grape powder supplementation prevents oxidative stress-induced anxiety-like behavior, memory impairment, and high blood pressure in rats. Journal of Nutrition 2013, 143(6):835-842.
6. Arcego D.M., Krolow R., Lampert C., Noschang C., Pettenuzzo L.F., Marcolin M.L., Toniazzo A.P., Dalmaz C. Stress during the pre-pubertal period leads to long-term diet-dependent changes in anxiety-like behavior and in oxidative stress parameters in male adult rats. Neurochemical Research 2013, 38(9):1791-1800.
7. Arora T., Mehta A.K., Sharma K.K., Mediratta P.K., Banerjee B.D., Garg G.R., Sharma A.K. Effect of carbamazepine and lamotrigine on cognitive function and oxidative stress in brain during chemical epileptogenesis in rats. Basic & Clinical Pharmacology & Toxicology 2009, 106:372-377.
8. Benotti M.J., Trenholm R.A., Vanderford B.J., Holady J.C., Stanford B.D., Snyder S.A. Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environmental Science & Technology 2009, 43:597-603.
9. Blaser R.E., Peñalosa Y.M. Stimuli affecting zebrafish (Danio rerio) behavior in the light/dark preference test. Physiology & Behavior 2011, 104:831-837.
10. Bouayed J., Rammal H., Soulimani R. Oxidative stress and anxiety: relationship and cellular pathways. Oxidative Medicine and Cellular Longevity 2009, 2:63-67.
11. Boxall A.B., Rudd M., Brooks B.W., Caldwell D., Choi K., Hickmann S., Innes E., Ostapyk K., Staveley J.P., Verslycke T. Pharmaceuticals and personal care products in the environment: what are the big questions. Environmental Health Perspectives 2012, 120:1221-1229.
12. Brackenbury T.D., Appleton C.C. Acute toxicity evaluation of the plant molluscicide, Apodytes dimidiata (Icacinaceae), to Eisenia fetida (Oligochaeta) and Oreochromis mossambicus (Cichlidae) in South Africa. Acta Tropica 1997, 63:1-14.
13. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:248-254.
14. Brodin T., Fick J., Jonsson M., Klaminder J. Dilute concentrations of a psychiatric drug alter behavior of fish from natural populations. Science 2013, 339:814-815.
15. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods in Enzymology 1978, 52:302-310.
16. Calisto V., Domingues M.R.M., Esteves V.I. Photodegradation of psychiatric pharmaceuticals in aquatic environments-kinetics and photodegradation products. Water Research 2011, 45:6097-6106.
17. Carlberg I., Mannervik B. Glutathione reductase. Methods in Enzymology 1985, 113:484-490.
18. Castro B.B., Gonçalves F. Seasonal dynamics of the crustacean zooplankton of a shallow eutrophic lake from the Mediterranean region. Fundamental and Applied Limnology/Archiv für Hydrobiologie 2007, 169:189-202.
19. Castro B.B., Gonçalves F. Planktivory in non-indigenous fish and implications for trophic interactions in a Mediterranean shallow lake. Annales de Limnologie - International Journal of Limnology 2011, 47:269-280.
20. Cernak I., Savic V., Kotur J., Prokic V., Kuljic B., Grbovic D., Veljovic M. Alterations in magnesium and oxidative status during chronic emotional stress. Magnesium Research 2000, 13:29-36.
21. Correia A.D., Costa M.H., Luis O.J., Livingstone D.R. Age-related changes in antioxidant enzyme activities, fatty acid composition and lipid peroxidation in whole body Gammarus locusta (Crustacea: Amphipoda). Journal of Experimental Marine Biology and Ecology 2003, 289:83-101.
22. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environmental Health Perspectives 1999, 107(Suppl. 6):907-938.
23. De Lange H.J., Noordoven W., Murk A.J., Lürling M., Peeters E.T.H.M. Behavioural responses of Gammarus pulex (Crustacea, Amphipoda) to low concentrations of pharmaceuticals. Aquatic Toxicology 2006, 78:209-216.
24. De Lange H.J., Peeters E.T.H.M., Lürling M. Changes in ventilation and locomotion of Gammarus pulex (Crustacea, Amphipoda) in response to low concentrations of pharmaceuticals. Human and Ecological Risk Assessment: An International Journal 2009, 15:111-120.
25. El-Sokkary G.H. Melatonin and vitamin C administration ameliorate diazepam-induced oxidative stress and cell proliferation in the liver of rats. Cell Proliferation 2008, 41:168-176.
26. Fent K., Weston A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquatic Toxicology 2006, 76:122-159.
27. Ferrari B., Paxéus N., Lo Giudice R., Pollio A., Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicology and Environment Safety 2003, 55:359-370.
28. Gallagher E.P., Sheehy K.M. Effects of phenytoin on glutathione status and oxidative stress biomarker gene mRNA levels in cultured precision human liver slices. Toxicological Sciences 2001, 59:118-126.
29. Gebauer D.L., Pagnussat N., Piato Â.L., Schaefer I.C., Bonan C.D., Lara D.R. Effects of anxiolytics in zebrafish: Similarities and differences between benzodiazepines, buspirone and ethanol. Pharmacology Biochemistry and Behavior 2011, 99:480-486.
30. Gingrich J.A. Oxidative stress is the new stress. Nature Medicine 2005, 11:1281-1282.
31. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry 1974, 249:7130-7139.
32. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 1999, Oxford University Press. 3rd edition.
33. Hascoët M., Bourin M., Nic Dhonnchadha B.Á. The mouse light-dark paradigm: a review. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2001, 25:141-166.
34. Hilscherova K., Blankenship A.L., Nie M., Coady K.K., Upham B.L., Trosko J.E., Giesy J.P. Oxidative stress in liver and brain of the hatchling chicken (Gallus domesticus) following in ovo injection with TCDD. Comparative Biochemistry and Physiology. Part C: Toxicology & Pharmacology 2003, 136:29-45.
35. Huang C.-H., Chang R.-J., Huang S.-L., Chen W. Dietary vitamin E supplementation affects tissue lipid peroxidation of hybrid tilapia, Oreochromis niloticus×O. aureus. Comparative Biochemistry and Physiology. Part B: Biochemistry and Molecular Biology 2003, 134:265-270.
36. Irons T.D., MacPhail R.C., Hunter D.L., Padilla S. Acute neuroactive drug exposures alter locomotor activity in larval zebrafish. Neurotoxicology and Teratology 2010, 32:84-90.
37. Jones O.A.H., Voulvoulis N., Lester J.N. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Research 2002, 36:5013-5022.
38. Jos A., Repetto G., Rios J., Hazen M., Molero M., del Peso A., Salguero M., Fernández-Freire P., Pérez-Martín J., Cameán A. Ecotoxicological evaluation of carbamazepine using six different model systems with eighteen endpoints. Toxicology in Vitro 2003, 17:525-532.
39. Kasapinovic S., McCallum G.P., Wiley M.J., Wells P.G. The peroxynitrite pathway in development: phenytoin and benzo[a]pyrene embryopathies in inducible nitric oxide synthase knockout mice. Free Radical Biology and Medicine 2004, 37:1703-1711.
40. Kuo C.-C. A common anticonvulsant binding site for phenytoin, carbamazepine, and lamotrigine in neuronal Na+ channels. Molecular pharmacology 1998, 54:712-721.
41. Kuo C.C., Chen R.S., Lu L., Chen R.C. Carbamazepine inhibition of neuronal Na+ currents: quantitative distinction from phenytoin and possible therapeutic implications. Molecular Pharmacology 1997, 51:1077-1083.
42. Li Z.-H., Li P., Randak T. Effect of a human pharmaceutical carbamazepine on antioxidant responses in brain of a model teleost in vitro: an efficient approach to biomonitoring. Journal of Applied Toxicology 2010, 30:644-648.
43. Li Z.-H., Li P., Rodina M., Randak T. Effect of human pharmaceutical Carbamazepine on the quality parameters and oxidative stress in common carp (Cyprinus carpio L.) spermatozoa. Chemosphere 2010, 80:530-534.
44. Li Z.H., Randak T. Residual pharmaceutically active compounds (PhACs) in aquatic environment-status, toxicity and kinetics: a review. Veterinarni Medicina 2009, 54:295-314.
45. Li Z.-H., Zlabek V., Velisek J., Grabic R., Machova J., Kolarova J., Li P., Randak T. Acute toxicity of carbamazepine to juvenile rainbow trout (Oncorhynchus mykiss): effects on antioxidant responses, hematological parameters and hepatic EROD. Ecotoxicology and Environmental Safety 2011, 74:319-327.
46. Li Z.-H., Zlabek V., Velisek J., Grabic R., Machova J., Randak T. Modulation of antioxidant defence system in brain of rainbow trout (Oncorhynchus mykiss) after chronic carbamazepine treatment. Comparative Biochemistry and Physiology. Part C: Toxicology & Pharmacology 2010, 151:137-141.
47. Liu C.S., Wu H.M., Kao S.H., Wei Y.H. Serum trace elements, glutathione, copper/zinc superoxide dismutase, and lipid peroxidation in epileptic patients with phenytoin or carbamazepine monotherapy. Clinical Neuropharmacology 1998, 21:62-64.
48. Liu J., Mori A. Stress, aging, and brain oxidative damage. Neurochemical Research 1999, 24:1479-1497.
49. Liu J., Wang X., Shigenaga M.K., Yeo H.C., Mori A., Ames B.N. Immobilization stress causes oxidative damage to lipid, protein, and DNA in the brain of rats. FASEB Journal 1996, 10:1532-1538.
50. Livingstone D.R. Contaminant-stimulated reactive oxygen species production and oxidative damage in aquatic organisms. Marine Pollution Bulletin 2001, 42:656-666.
51. Mahle C., Dasgupta A. Decreased total antioxidant capacity and elevated lipid hydroperoxide concentrations in sera of epileptic patients receiving phenytoin. Life sciences 1997, 61:437-443.
52. Martin-Diaz L., Franzellitti S., Buratti S., Valbonesi P., Capuzzo A., Fabbri E. Effects of environmental concentrations of the antiepilectic drug carbamazepine on biomarkers and cAMP-mediated cell signaling in the mussel Mytilus galloprovincialis. Aquatic Toxicology 2009, 94:177-185.
53. Maximino C., Marques de Brito T., Dias C.A.G., de M., Gouveia A., Morato S. Scototaxis as anxiety-like behavior in fish. Nature Protocols 2010, 5:209-216.
54. Metcalfe C.D., Koenig B.G., Bennie D.T., Servos M., Ternes T.A., Hirsch R. Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environmental Toxicology and Chemistry 2003, 22:2872-2880.
55. Metcalfe C.D., Miao X.-S., Koenig B.G., Struger J. Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environmental Toxicology and Chemistry 2003, 22:2881-2889.
56. Musavi S., Kakkar P. Diazepam induced early oxidative changes at the subcellular level in rat brain. Molecular and cellular biochemistry 1998, 178:41-46.
57. Musavi S., Kakkar P. Effect of diazepam treatment and its withdrawal on pro/antioxidative processes in rat brain. Molecular and Cellular Biochemistry 2003, 245:51-56.
58. Nassef M., Matsumoto S., Seki M., Khalil F., Kang I.J., Shimasaki Y., Oshima Y., Honjo T. Acute effects of triclosan, diclofenac and carbamazepine on feeding performance of Japanese medaka fish (Oryzias latipes). Chemosphere 2010, 80:1095-1100.
59. Nelson M.H., Birnbaum A.K., Remmel R.P. Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors. Epilepsy Research 2001, 44(1):71-82.
60. Nowakowska E., Kus K., Czubak A., Glowacka D., Matschay A. Some behavioural effects of carbamazepine-comparison with haloperidol. Journal of Physiology and Pharmacology 2007, 58:253.
61. Nunes B., Carvalho F., Guilhermino L. Effects of widely used pharmaceuticals and a detergent on oxidative stress biomarkers of the crustacean Artemia parthenogenetica. Chemosphere 2006, 62:581-594.
62. Nunes B., Gaio A.R., Carvalho F., Guilhermino L. Behaviour and biomarkers of oxidative stress in Gambusia holbrooki after acute exposure to widely used pharmaceuticals and a detergent. Ecotoxicology and Environmental Safety 2008, 71:341-354.
63. OECD OECD Guideline for Testing of Chemicals 1992, vol. 203:1-9.
64. Oggier D.M., Weisbrod C.J., Stoller A.M., Zenker A.K., Fent K. Effects of diazepam on gene expression and link to physiological effects in different life stages in zebrafish Danio rerio. Environmental Science & Technology 2010, 44:7685-7691.
65. Raya A., Gallego J., Bosch-Morell F., Romá J., Romero F.J. Phenytoin-induced glutathione depletion in rat peripheral nerve. Free Radical Biology and Medicine 1995, 19:665-667.
66. Reeta K.H., Mehla J., Gupta Y.K. Curcumin is protective against phenytoin-induced cognitive impairment and oxidative stress in rats. Brain Research 2009, 1301:52-60.
67. Riehl R., Kyzar E., Allain A., Green J., Hook M., Monnig L., Rhymes K., Roth A., Pham M., Razavi R., DiLeo J., Gaikwad S., Hart P., Kalueff A.V. Behavioral and physiological effects of acute ketamine exposure in adult zebrafish. Neurotoxicology and Teratology 2011, 33:658-667.
68. Roberts P., Thomas K. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Science of the Total Environment 2006, 356:143-153.
69. Rodrigues S., Antunes S.C., Brandão F.P., Castro B.B., Gonçalves F., Nunes B. Effects of anticholinesterase drugs on biomarkers and behavior of pumpkinseed, Lepomis gibbosus (Linnaeus, 1758). Journal of Environmental Monitoring 2012, 14:1638.
70. Saïas T., Gallarda T. Paradoxical aggressive reactions to benzodiazepine use: a review. Encephale 2008, 34:330-336.
71. Sanderson H., Johnson D.J., Reitsma T., Brain R.A., Wilson C.J., Solomon K.R. Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. Regulatory Toxicology and Pharmacology 2004, 39:158-183.
72. Schrap S.M., Rijs G.B., Beek M.A., Maaskant J.F., Staeb J., Stroomberg G., Tiesnitsch J. Humane en veterinaire geneesmiddelen in Nederlands oppervlaktewater en afvalwater. RIZA Report 2003, 86.
73. Scott G.R., Sloman K.A. The effects of environmental pollutants on complex fish behaviour: integrating behavioural and physiological indicators of toxicity. Aquatic Toxicology 2004, 68:369-392.
74. 2+-ATPase activity in rat liver. Acta Biologica Hungarica 2007, 58:441-443.
75. Serra E.L., Medalha C.C., Mattioli R. Natural preference of zebrafish (Danio rerio) for a dark environment. Brazilian Journal of Medical and Biological Research 1999, 32:1551-1553.
76. Smith D.F. Lithium and carbamazepine: effects on learned taste aversion and open field behavior in rats. Pharmacology Biochemistry and Behavior 1983, 18:483-488.
77. Steenbergen P.J., Richardson M.K., Champagne D.L. Patterns of avoidance behaviours in the light/dark preference test in young juvenile zebrafish: a pharmacological study. Behavioural Brain Research 2011, 222:15-25.
78. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers1. Water Research 1998, 32:3245-3260.
79. Thomas K.V., Dye C., Schlabach M., Langford K.H. Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works. Journal of Environmental Monitoring 2007, 9:1410.
80. Van den Brandhof E.-J., Montforts M. Fish embryo toxicity of carbamazepine, diclofenac and metoprolol. Ecotoxicology and Environmental Safety 2010, 73:1862-1866.
81. Van der Oost R., Beyer J., Vermeulen N.P. Fish bioaccumulation and biomarkers in environmental risk assessment: a review. Environmental Toxicology and Pharmacology 2003, 13:57-149.
82. Vernouillet G., Eullaffroy P., Lajeunesse A., Blaise C., Gagné F., Juneau P. Toxic effects and bioaccumulation of carbamazepine evaluated by biomarkers measured in organisms of different trophic levels. Chemosphere 2010, 80:1062-1068.
83. Vollert C., Zagaar M., Hovatta I., Taneja M., Vu A., Dao A., Levine A., Alkadhi K., Salima S. Exercise prevents sleep deprivation-associated anxiety-like behavior in rats: potential role of oxidative stress mechanisms. Behavioural Brain Research 2011, 224:233-240.
84. Weinberger D.R. Anxiety at the frontier of molecular medicine. New England Journal of Medicine 2001, 344:1247-1249.
85. Yamamura S., Hamaguchi T., Ohoyama K., Sugiura Y., Suzuki D., Kanehara S., Nakagawa M., Motomura E., Matsumoto T., Tanii H., Shiroyama T., Okada M. Topiramate and zonisamide prevent paradoxical intoxication induced by carbamazepine and phenytoin. Epilepsy Research 2009, 84:172-186.
86. Yu J.T., Bouwer E.J., Coelhan M. Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent. Agricultural Water Management 2006, 86:72-80.
87. Zhang Y., Geißen S-U. Prediction of carbamazepine in sewage treatment plant effluents and its implications for control strategies of pharmaceutical aquatic contamination. Chemosphere 2010, 80(11):1345-1352.
88. Zhou X.F., Dai C.M., Zhang Y.L., Surampalli R.Y., Zhang T.C. A preliminary study on the occurrence and behavior of carbamazepine (CBZ) in aquatic environment of Yangtze River Delta, China. Environmental Monitoring and Assessment 2011, 173:45-53.
89. Zuccato E., Calamari D., Natangelo M., Fanelli R. Presence of therapeutic drugs in the environment. Lancet 2000, 355:1789-1790.